Lidocaine Hydrochloride Noridem

Lidocaine Hydrochloride, the active ingredient in Lidocaine Hydrochloride Noridem, is a local anesthetic presented as a sterile solution for epidural, intradermal and intramuscular use. It provides reversible nerve impulse blockade for minor surgical, diagnostic and analgesic procedures in adult patients.

GNH USA supplies Lidocaine Hydrochloride Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Hydrochloride is used in clinical settings where rapid, reversible loss of sensation is required for procedures involving peripheral nerves or skin. - Minor surgical procedures: provides local anesthesia to enable painless incision and manipulation. - Epidural analgesia: delivers regional pain relief during labor or postoperative recovery. - Intradermal skin testing: numbs the skin to reduce discomfort during allergy or diagnostic testing. - Intramuscular nerve block: creates targeted anesthesia for muscle‑related interventions.

Lidocaine Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Injection site pain or burning sensation. - Redness or swelling at the site of administration. - Dizziness or light‑headedness. - Metallic taste or mild nausea. - Temporary numbness extending beyond the target area.

Serious or Rare Side Effects: - Central nervous system toxicity such as seizures or severe tremors. - Cardiac arrhythmias, hypotension, or cardiac arrest. - Respiratory depression or apnea. - Allergic reactions including rash, angioedema, or anaphylaxis. - Methemoglobinemia, a rare blood disorder causing reduced oxygen delivery.

Before using Lidocaine Hydrochloride, clinicians should consider several safety measures. - Allergy assessment: confirm no known hypersensitivity to amide‑type local anesthetics. - Cardiac monitoring: observe patients with pre‑existing heart disease or conduction abnormalities. - Dose calculation: adjust total dose based on patient weight and age to avoid systemic toxicity. - Concomitant drugs: review concurrent use of other sodium channel blockers or CNS depressants. - Pregnancy and lactation: evaluate risk‑benefit ratio as safety data are limited. - Store below 25°C: keep in original container, protect from moisture and light.

Lidocaine Hydrochloride can interact with other medications, influencing its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may potentiate cardiac toxicity. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can increase systemic lidocaine levels.

Moderate Interactions (Monitor Closely): - Beta‑adrenergic blockers and calcium channel blockers: may enhance hypotensive effects. - Other local anesthetics: cumulative dosing can raise risk of neuro‑cardiac toxicity. - Monoamine oxidase inhibitors (MAOIs): may augment CNS side effects.